Cours Islet Sciences Inc OTC Bulletin Board

Actions

Cours en clôture OTC Bulletin Board
- ^USD	-

04/05/15	Islet Sciences, Inc. Publishes Data Supporting Remogliflozin Etabonate as a Potential Treatment for NAFLD and NASH
23/04/15	Islet Sciences, Inc. Presented at 50th International Liver Conference
24/03/15	Islet Sciences, Inc. COO to Present at Metabolic Leaders Forum
09/03/15	Islet Sciences, Inc. COO to Present at EASL: Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)
05/03/15	Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD

Ajouter à une liste 0 sélectionné Pour utiliser cette fonction vous devez être client ou membre Connexion Inscription	Varia.	Varia. 5j.	Varia. 1an	Varia. 3ans	Capi.($)
LONZA GROUP AG	+0,59%	+3,31%	+1,03%	+24,53%	46,28 Md
IQVIA HOLDINGS INC.	+1,30%	+3,10%	+44,15%	+31,38%	43,85 Md
REVOLUTION MEDICINES, INC.	+0,95%	-5,40%	+342,72%	+548,37%	40,93 Md
BEONE MEDICINES AG	+4,23%	+5,53%	+9,35%	+89,62%	39,89 Md
CELLTRION, INC.	+1,11%	+1,80%	+11,52%	+43,15%	29,5 Md
MEDPACE HOLDINGS, INC.	+1,94%	+6,24%	+25,19%	+145,07%	17,09 Md
ASCENDIS PHARMA A/S	+0,37%	-9,84%	-	-	15,55 Md
EUROFINS SCIENTIFIC SE	+2,12%	+10,41%	+24,78%	+39,05%	15,22 Md
TEMPUS AI, INC.	+0,24%	+32,23%	-11,57%	-	14,05 Md
Moyenne	+1,46%	+3,97%	+55,90%	+131,60%	29,15 Md
Moyenne pondérée par Capi.	+1,59%	+2,08%	+70,37%	+141,24%